CARTA HOLDINGS, INC. Logo

CARTA HOLDINGS, INC.

Digital marketing firm offering ad platforms and integrated solutions to empower businesses.

3688 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
港区虎ノ門二丁目6番1号虎ノ門ヒルズステーションタワー36階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CARTA HOLDINGS, INC. is a diversified company operating in the digital marketing and internet services sectors. The firm provides comprehensive, integrated marketing solutions, from strategic planning to execution. Its core activities include acting as a media representative, operating proprietary ad delivery platforms, and managing sales promotion-related online media. The service portfolio covers digital advertising, social media management, and web search marketing. Positioning itself as 'The Evolution Factory,' the company leverages its digital expertise to develop innovative services and content designed to empower businesses and drive industry growth.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-18 05:33
Proxy Solicitation & Information Statement
意見表明報告書
Japanese 432.8 KB
2025-08-08 08:30
Interim Report
確認書
Japanese 9.1 KB
2025-08-08 08:30
Interim Report
半期報告書-第27期(2025/01/01-2025/12/31)
Japanese 219.2 KB
2025-03-31 08:32
Post-Annual General Meeting Information
臨時報告書
Japanese 24.2 KB
2025-03-31 08:31
Registration Form
確認書
Japanese 9.1 KB
2025-03-31 08:30
Governance Information
内部統制報告書-第26期(2024/01/01-2024/12/31)
Japanese 24.1 KB
2025-03-31 08:30
Annual Report
有価証券報告書-第26期(2024/01/01-2024/12/31)
Japanese 1.3 MB
2024-08-09 08:00
Interim Report
確認書
Japanese 9.3 KB
2024-08-09 08:00
Interim Report
半期報告書-第26期(2024/01/01-2024/12/31)
Japanese 246.2 KB
2024-06-06 08:00
Major Shareholding Notification
変更報告書
Japanese 39.6 KB
2024-06-05 08:00
Major Shareholding Notification
変更報告書
Japanese 39.4 KB
2024-05-14 08:00
Share Issue/Capital Change
訂正臨時報告書
Japanese 35.2 KB
2024-05-13 08:01
Report Publication Announcement
確認書
Japanese 9.4 KB
2024-05-13 08:00
Quarterly Report
四半期報告書-第26期第1四半期(2024/01/01-2024/03/31)
Japanese 179.6 KB
2024-04-26 08:09
Share Issue/Capital Change
臨時報告書
Japanese 36.4 KB

Automate Your Workflow. Get a real-time feed of all CARTA HOLDINGS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CARTA HOLDINGS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.
Japan 4771
FRIENDLY CORPORATION Logo
Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.
Japan 8209
FunPep Company Limited Logo
Biotech firm developing peptide-based therapeutics, cosmetics, and medical devices.
Japan 4881
GECOSS CORPORATION Logo
Leases and sells temporary steel materials and equipment for large construction projects.
Japan 9991
GENDAI AGENCY INC. Logo
Advertising agency providing marketing and promotions for the pachinko industry.
Japan 2411
Geneuro Logo
Developing antibody therapies targeting pathogenic HERVs for MS and post-COVID syndromes.
Switzerland GEM
Developing long-acting immunotherapeutics for immuno-oncology and rare diseases.
South Korea 095700
GENFLOW BIOSCIENCES PLC Logo
Develops gene therapies to slow aging and treat age-related diseases in humans and dogs.
United Kingdom GENF
GENINUS Inc. Logo
AI-powered genomic and multi-omics analysis for precision medicine and clinical partners.
South Korea 389030
genOway Logo
Develops custom genetically modified preclinical models for biopharma and academic research.
France ALGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.